Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients

George Kaysen, Joel A. Dubin, Hans Georg Müller, Laura Rosales, Nathan W. Levin, William E. Mitch

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Background. The concentration of albumin in serum is maintained by its rates of synthesis, catabolism, and distribution between vascular and extravascular compartments. Albumin synthesis is suppressed when there is inflammation or inadequate protein intake. This study was conducted to establish whether a decline in serum albumin of >0.3 g/dL was accompanied by a change in albumin synthesis and if so whether these changes were associated with increased levels of acute phase proteins and/or with a decrease in equilibrated normalized protein catabolic rate (enPCR). Methods. Seventy-nine patients in the National Institutes of Health (NIH)-sponsored HEMO Study had baseline measurements of albumin synthesis (measured kinetically as the disappearance of [125]I human serum albumin), the serum concentrations of albumin, transferrin, C-reactive protein (CRP), α1 acid glycoprotein (α1AG), ceruloplasmin, interleukin-6 (IL-6), plus monthly measurements of enPCR. The plasma levels of all proteins and enPCR were measured regularly over 2 years or until serum albumin decreased by >0.3 g/ dL on two sequential measurements. Albumin synthesis was measured a second time when serum albumin declined by >0.3 g/dL or after 2 years. Results. Fifty-nine patients [21 with a significant decrease in serum albumin (decliners) and 38 with stable values of serum albumin] had albumin synthesis measured twice. A decline in albumin concentration and synthesis was associated with an increase in α1AG when data from all patients were analyzed as a group. In decliners, albumin synthesis decreased significantly but was unchanged in stable. Likewise, in decliners, IL-6, CRP, α1AG, and ceruloplasmin increased significantly but were unchanged in stable. enPCR was unchanged in both groups and was not associated with either changes in albumin level or synthesis in the whole group. Conclusion. A decrease in serum albumin of >0. 3 g/dL that persists for a period of 6 weeks is associated a decrease in albumin synthesis. This response is associated with evidence of activation of the acute phase response (inflammation) but not with changes in enPCR. In well-dialyzed patients, inflammation is the principal cause of a decrease in serum albumin while protein intake plays an insignificant role.

Original languageEnglish (US)
Pages (from-to)1408-1415
Number of pages8
JournalKidney International
Volume65
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Serum Albumin
Renal Dialysis
Albumins
Inflammation
Proteins
Glycoproteins
Ceruloplasmin
C-Reactive Protein
Acids
Interleukin-6
Acute-Phase Reaction
Acute-Phase Proteins
National Institutes of Health (U.S.)
Transferrin
Blood Vessels

Keywords

  • α1 acid glycoprotein
  • Albumin synthesis
  • Ceruloplasmin
  • CRP
  • Inflammation
  • Nutrition

ASJC Scopus subject areas

  • Nephrology

Cite this

Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. / Kaysen, George; Dubin, Joel A.; Müller, Hans Georg; Rosales, Laura; Levin, Nathan W.; Mitch, William E.

In: Kidney International, Vol. 65, No. 4, 04.2004, p. 1408-1415.

Research output: Contribution to journalArticle

Kaysen, George ; Dubin, Joel A. ; Müller, Hans Georg ; Rosales, Laura ; Levin, Nathan W. ; Mitch, William E. / Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. In: Kidney International. 2004 ; Vol. 65, No. 4. pp. 1408-1415.
@article{ec5893cb99774ec88a47f34692644e8e,
title = "Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients",
abstract = "Background. The concentration of albumin in serum is maintained by its rates of synthesis, catabolism, and distribution between vascular and extravascular compartments. Albumin synthesis is suppressed when there is inflammation or inadequate protein intake. This study was conducted to establish whether a decline in serum albumin of >0.3 g/dL was accompanied by a change in albumin synthesis and if so whether these changes were associated with increased levels of acute phase proteins and/or with a decrease in equilibrated normalized protein catabolic rate (enPCR). Methods. Seventy-nine patients in the National Institutes of Health (NIH)-sponsored HEMO Study had baseline measurements of albumin synthesis (measured kinetically as the disappearance of [125]I human serum albumin), the serum concentrations of albumin, transferrin, C-reactive protein (CRP), α1 acid glycoprotein (α1AG), ceruloplasmin, interleukin-6 (IL-6), plus monthly measurements of enPCR. The plasma levels of all proteins and enPCR were measured regularly over 2 years or until serum albumin decreased by >0.3 g/ dL on two sequential measurements. Albumin synthesis was measured a second time when serum albumin declined by >0.3 g/dL or after 2 years. Results. Fifty-nine patients [21 with a significant decrease in serum albumin (decliners) and 38 with stable values of serum albumin] had albumin synthesis measured twice. A decline in albumin concentration and synthesis was associated with an increase in α1AG when data from all patients were analyzed as a group. In decliners, albumin synthesis decreased significantly but was unchanged in stable. Likewise, in decliners, IL-6, CRP, α1AG, and ceruloplasmin increased significantly but were unchanged in stable. enPCR was unchanged in both groups and was not associated with either changes in albumin level or synthesis in the whole group. Conclusion. A decrease in serum albumin of >0. 3 g/dL that persists for a period of 6 weeks is associated a decrease in albumin synthesis. This response is associated with evidence of activation of the acute phase response (inflammation) but not with changes in enPCR. In well-dialyzed patients, inflammation is the principal cause of a decrease in serum albumin while protein intake plays an insignificant role.",
keywords = "α1 acid glycoprotein, Albumin synthesis, Ceruloplasmin, CRP, Inflammation, Nutrition",
author = "George Kaysen and Dubin, {Joel A.} and M{\"u}ller, {Hans Georg} and Laura Rosales and Levin, {Nathan W.} and Mitch, {William E.}",
year = "2004",
month = "4",
doi = "10.1111/j.1523-1755.2004.00520.x",
language = "English (US)",
volume = "65",
pages = "1408--1415",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients

AU - Kaysen, George

AU - Dubin, Joel A.

AU - Müller, Hans Georg

AU - Rosales, Laura

AU - Levin, Nathan W.

AU - Mitch, William E.

PY - 2004/4

Y1 - 2004/4

N2 - Background. The concentration of albumin in serum is maintained by its rates of synthesis, catabolism, and distribution between vascular and extravascular compartments. Albumin synthesis is suppressed when there is inflammation or inadequate protein intake. This study was conducted to establish whether a decline in serum albumin of >0.3 g/dL was accompanied by a change in albumin synthesis and if so whether these changes were associated with increased levels of acute phase proteins and/or with a decrease in equilibrated normalized protein catabolic rate (enPCR). Methods. Seventy-nine patients in the National Institutes of Health (NIH)-sponsored HEMO Study had baseline measurements of albumin synthesis (measured kinetically as the disappearance of [125]I human serum albumin), the serum concentrations of albumin, transferrin, C-reactive protein (CRP), α1 acid glycoprotein (α1AG), ceruloplasmin, interleukin-6 (IL-6), plus monthly measurements of enPCR. The plasma levels of all proteins and enPCR were measured regularly over 2 years or until serum albumin decreased by >0.3 g/ dL on two sequential measurements. Albumin synthesis was measured a second time when serum albumin declined by >0.3 g/dL or after 2 years. Results. Fifty-nine patients [21 with a significant decrease in serum albumin (decliners) and 38 with stable values of serum albumin] had albumin synthesis measured twice. A decline in albumin concentration and synthesis was associated with an increase in α1AG when data from all patients were analyzed as a group. In decliners, albumin synthesis decreased significantly but was unchanged in stable. Likewise, in decliners, IL-6, CRP, α1AG, and ceruloplasmin increased significantly but were unchanged in stable. enPCR was unchanged in both groups and was not associated with either changes in albumin level or synthesis in the whole group. Conclusion. A decrease in serum albumin of >0. 3 g/dL that persists for a period of 6 weeks is associated a decrease in albumin synthesis. This response is associated with evidence of activation of the acute phase response (inflammation) but not with changes in enPCR. In well-dialyzed patients, inflammation is the principal cause of a decrease in serum albumin while protein intake plays an insignificant role.

AB - Background. The concentration of albumin in serum is maintained by its rates of synthesis, catabolism, and distribution between vascular and extravascular compartments. Albumin synthesis is suppressed when there is inflammation or inadequate protein intake. This study was conducted to establish whether a decline in serum albumin of >0.3 g/dL was accompanied by a change in albumin synthesis and if so whether these changes were associated with increased levels of acute phase proteins and/or with a decrease in equilibrated normalized protein catabolic rate (enPCR). Methods. Seventy-nine patients in the National Institutes of Health (NIH)-sponsored HEMO Study had baseline measurements of albumin synthesis (measured kinetically as the disappearance of [125]I human serum albumin), the serum concentrations of albumin, transferrin, C-reactive protein (CRP), α1 acid glycoprotein (α1AG), ceruloplasmin, interleukin-6 (IL-6), plus monthly measurements of enPCR. The plasma levels of all proteins and enPCR were measured regularly over 2 years or until serum albumin decreased by >0.3 g/ dL on two sequential measurements. Albumin synthesis was measured a second time when serum albumin declined by >0.3 g/dL or after 2 years. Results. Fifty-nine patients [21 with a significant decrease in serum albumin (decliners) and 38 with stable values of serum albumin] had albumin synthesis measured twice. A decline in albumin concentration and synthesis was associated with an increase in α1AG when data from all patients were analyzed as a group. In decliners, albumin synthesis decreased significantly but was unchanged in stable. Likewise, in decliners, IL-6, CRP, α1AG, and ceruloplasmin increased significantly but were unchanged in stable. enPCR was unchanged in both groups and was not associated with either changes in albumin level or synthesis in the whole group. Conclusion. A decrease in serum albumin of >0. 3 g/dL that persists for a period of 6 weeks is associated a decrease in albumin synthesis. This response is associated with evidence of activation of the acute phase response (inflammation) but not with changes in enPCR. In well-dialyzed patients, inflammation is the principal cause of a decrease in serum albumin while protein intake plays an insignificant role.

KW - α1 acid glycoprotein

KW - Albumin synthesis

KW - Ceruloplasmin

KW - CRP

KW - Inflammation

KW - Nutrition

UR - http://www.scopus.com/inward/record.url?scp=1642545155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642545155&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2004.00520.x

DO - 10.1111/j.1523-1755.2004.00520.x

M3 - Article

C2 - 15086482

AN - SCOPUS:1642545155

VL - 65

SP - 1408

EP - 1415

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 4

ER -